News
-
November 10, 2023
SARASOTA, Fla., November 10, 2023 /PRNewswire/ -- World Precision Instruments (WPI), a leading provider of high-quality laboratory instruments and equipment for basic research and drug development, is proud to announce the establishment of its Scientific Advisory Board (SAB). Comprised of renowned experts in various scientific disciplines, the SAB will play a crucial role in guiding and advancing WPI's commitment to innovation and excellence in scientific research...more
-
October 24, 2023
SARASOTA, Fla., October 23, 2023 /PRNewswire/ -- World Precision Instruments (WPI) is excited to expand the capability of the EVOM™ Auto, now offering both 24 and 96 multiwell capacity in one single platform. The EVOM™ Auto enables rapid and reproducible measurements of Transepithelial Electrical Resistance (TEER), a well-established, non-invasive and widely accepted method of evaluating epithelial and endothelial cells and tissues. ...more
-
October 06, 2023
The foundation of many research laboratories is the ability to do in vitro studies, which rely on the ability to culture cells in the laboratory. Cell culture technologies have advanced significantly, allowing researchers to successfully culture many types of cell lines...more
-
September 01, 2023
WPI was recently featured in Aviation Week as a supplier of stainless steel mesh baskets for manufacturing and electronics...more
-
August 17, 2023
On December 29, 2022, the FDA Modernization Act 2.0 was signed into law, which allows alternatives to animal testing for new drug development. This has opened the door for new pathways to drug discovery and development that involve Artificial Intelligence, cell culture-based assays, and organ-on-chip applications. It also moved the field closer to the three Rs of animal testing:...more
-
June 27, 2023
In 2022, the United States Food and Drug Administration (FDA) approved 37 new drugs, of which 20 were chemical entities and 17 were biologics. In 2023, drug discovery remains strong with many new advancements a result of changing landscapes in both the types of drugs that are being developed and the new and innovative assay that are being launched to evaluate drugs preclinically. Therapeutic development is still highly focused on diseases that affect large populations of people for which there are lack of effective treatments, with 2023’s most anticipated drug launches expected to be in areas of cancer, Alzheimer’s disease, cardiovascular disease, and ulcerative colitis...more
-
April 13, 2023World Precision Instruments (WPI) is excited to launch the newest member to its EVOM™ family of products, the EVOM™ Auto. The new EVOM™ Auto enables rapid and reproducible measurements of Transepithelial Electrical Resistance (TEER), a well-established and widely accepted method of evaluating epithelial and endothelial cells and tissues, in vitro. WPI’s EVOM™ Auto combines TEER technology with high throughput screening capabilities, resulting in the automated measurement of resistance in 96-well cell culture plates. This data gives scientists and drug discovery laboratories insights into tissue and monolayer barrier integrity, cell permeability, cell confluency, and can readout the critical physiology of barrier tissues such as the blood-brain barrier, the gastrointestinal tract, the lung, and the skin. ...more
-
January 25, 2023
The US FDA Modernization Act 2.0 replaces the 1938 Federal Food, Drug and Cosmetic Act which required animal testing prior to human trials. The new law, sponsored in the Senate by Rand Paul and co-sponsored by 11 other bi-partisan senators, eliminates that requirement. Representatives Vern Buchanan and Elaine Luria introduced the companion bill in the House, with over 105 bi-partisan cosponsors. President Biden signed the bill into law in December 2022. With the advent of modern research methods, we now have many options available to test the efficacy and safety of new pharmaceuticals without requiring the use of animals. Some of these methods include cell-based assays, microphysiological systems like organ-on-a chip (OOC), and bio-printed or computer models. In 2019, the cost of bringing a new drug to market varied greatly from $161...more
-
September 13, 2022WPI is very excited to announce our newest product launch and collaboration with MatTek Life Sciences. The companies will offer both MatTek PermaCell Cell Culture Insert Plates and compatible customized World Precision Instruments’ STX HTS EVOM™ Electrode for TEER to their respective customers, available immediately to the life sciences market...more
-
August 16, 2021
WPI Vision, a division of World Precision Instrument, launched earlier this year. WPI Vision is in the business of enriching the stereo macroscopic process through the use of patent-pending technology to provide an incomparable user experience to any other product in its price point. By leveraging advances in displays, CMOS sensors and processing power, WPI Vision is redefining how macroscopic needs and problems are being met and answered.
In August, WPI Vision announced the immediate availability of ERMA, the Enhanced Reality Microscope which offers a 3D experience. This is perfect for Electronic Assembly and Inspections, Printed Circuit Board Assembly, and many other applications. With over 35 claims on the patent, ERMA is setting new expectations for workstation throughput.
“...more
-
January 03, 2019
The Butantan Institute, an agency linked to the State Department of Health of São Paulo and one of the largest biomedical research centers in the world, held the 4th edition of the Zebrafish Creation and Management university extension course in December where they exhibited WPI's Zebrafish Microinjection System.
The training is aimed at professionals and post-graduate students involved in zebrafish research as an animal model. The program addressed the physical characteristics, the environment of origin and the way of reproduction and growth of this fish. The coordinators are the researchers Mônica Lopes Ferreira and Carla Lima, responsible for the Zebrafish Platform of CeTICS Butantan whose current capacity holds 6,000 adult fish.
https://www.redezebrafish.com.br/parceiros
...more -
October 08, 2018
Jonas de Jesus, from WPI Brasil visit the winner of a contest to name a mascot for the Zebrafish Network. Jonas presented the winner with a surgical kit for zebrafish research.
The project "The Zebrafish Network" is a result of the partnership of the Center for Toxins, Immune Response and Cell Signaling (CeTICS) of the Butantan Institute, and aims to promote communication and integration, as well as foster collaborations between researchers studying the fish "Paulistinha ", Which has been used for many scientific studies because of its genetic similarity with humans (70%).
"The idea is that everyone who belongs to the network can divulge their work, interact with other researchers and inform about what is happening, such as publication of articles, lectures and congresses on the subject," explains Mônica Lopes , director of the Special Laboratory of Toxicology and coordinator of the Zebrafish Platform.
Since the Zebrafish Platform opened in the IB in 2015, a network...more
-
April 14, 2017
World Precision Instruments was selected to receive the FVMA (Florida Veterinary Medical Association) Industry Award for 2017....more
-
October 09, 2015
See the full press release on WPI's rebranding. Discover the story behind the new look...more
-
November 20, 2013
WPI was recently featured in the Sarasota Daily. You can read the article here.